Page last updated: 2024-10-22

amlexanox and Myocardial Infarction

amlexanox has been researched along with Myocardial Infarction in 1 studies

amlexanox: SRA-A antagonist;structure given in first source
amlexanox : A pyridochromene-derived monocarboxylic acid having an amino substituent at the 2-position, an oxo substituent at the 5-position and an isopropyl substituent at the 7-position.

Myocardial Infarction: NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION).

Research Excerpts

ExcerptRelevanceReference
"The aim of this study was to study the effect of protein kinase TBK1 and IKKε inhibitor Amlexanox on cardiac function after acute myocardial infarction (AMI) in rats."8.31Protein kinase TBK1/IKKε inhibitor Amlexanox improves cardiac function after acute myocardial infarction in rats. ( Han, H; Lu, X; Luo, D; Mo, C; Tang, X; Wei, Y; Zhou, Z, 2023)
"The aim of this study was to study the effect of protein kinase TBK1 and IKKε inhibitor Amlexanox on cardiac function after acute myocardial infarction (AMI) in rats."4.31Protein kinase TBK1/IKKε inhibitor Amlexanox improves cardiac function after acute myocardial infarction in rats. ( Han, H; Lu, X; Luo, D; Mo, C; Tang, X; Wei, Y; Zhou, Z, 2023)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Mo, C1
Han, H1
Tang, X1
Lu, X1
Wei, Y1
Luo, D1
Zhou, Z1

Other Studies

1 other study available for amlexanox and Myocardial Infarction

ArticleYear
Protein kinase TBK1/IKKε inhibitor Amlexanox improves cardiac function after acute myocardial infarction in rats.
    Panminerva medica, 2023, Volume: 65, Issue:3

    Topics: Animals; Dimethyl Sulfoxide; I-kappa B Kinase; Myocardial Infarction; Protein Kinase Inhibitors; Rat

2023